Ned McWilliams is a shareholder at Levin Papantonio. He litigates pharmaceutical, environmental, mass tort and personal injury cases throughout the country. Mr. McWilliams has been appointed to leadership in many of the largest mass tort cases in the country.
Mr. McWilliams is presently serving on the Science and Discovery Committees in the Aqueous Film-Forming Foams (AFFF) Products Liability Litigation (MDL 2873) pending in United States District Court, District of South Carolina before the Honorable Richard Gergel. The AFFF MDL is a mass tort brought on behalf of water providers and other individuals who have been harmed by exposure to AFFF and/or required to incur cost associated with its remediation. The first bellwether trial is scheduled for January 2023.
On March 7, 2022, Mr. McWilliams was appointed as class counsel in Hardwick v. 3M Co. et al., case number 2:18-cv-01185, in the U.S. District Court for the Southern District of Ohio. The Hardwick class is comprised of every individual in the state of Ohio with measurable concentrations of certain PFAS chemicals. The case seeks redress in the means of requiring the manufactures of these chemicals to conduct robust comprehensive human testing to determine whether continued exposure is deemed safe.
Mr. McWilliams also served in leadership roles in In re: Xarelto Products Liability Litigation (MDL 2592); In Re: E. I. du Pont de Nemours and Company C-8 Personal Injury Litigation (MDL 2433); In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation (MDL 2385); and In Re: Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL 2100).
Mr. McWilliams is a frequent lecturer throughout the country on mass tort and environmental litigation.